Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma.
Back to Lifestyle
Lifestyle
October 5, 2026 at 1:55 PM
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
STAT News
Excerpt from STAT News.